Mono Pharmacare Ltd
Ticker: MONOPHARMA
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
21.00
Market Cap
37.10
Debt/Equity
1.7145
ROE %
10.342
PB
1.1877
Promoter %
56.724
Pledge %
0.000
1Y Rev Growth %
38.288
5Y Rev Growth %
NP Margin %
1.813
NP Margin 5Y Avg %
Trading Reference
1M Return %
-16.667
6M Return %
-17.485
1Y Return %
-39.130
% Away 52W High
80.952
% Away 52W Low
1.695
Daily Volume
2000
Investment Verdict
Hold
Score 72/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 17/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Mono Pharmacare Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If it breaks above the resistance level, there is a strong potential for upward movement. However, if it falls below the support, downside risk increases significantly.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
A
Abm International Ltd
Abm International Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
AIK Pipes and Polymers Ltd
AIK Pipes and Polymers Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Caution is advised.
View details
L
Laxmi Cotspin Ltd
Laxmi Cotspin Ltd shows potential in a growing sector but faces challenges in execution and profitability consistency.
View details
F
Future Enterprises Ltd
Future Enterprises Ltd presents significant risks with inconsistent growth and profitability metrics, alongside a challenging market environment.
View details
J
Johnson Pharmacare Ltd
Johnson Pharmacare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Advance Metering Technology Ltd
Advance Metering Technology Ltd shows potential in a growing sector, but faces challenges in execution and market competition.
View details
E
Ecofinity Atomix Ltd
Ecofinity Atomix Ltd shows potential but faces significant challenges in growth consistency and profitability metrics.
View details
D
Duropack Ltd
Duropack Ltd shows several weaknesses in growth, profitability, and market sentiment, making it a risky investment at this time.
View details
P
Picturehouse Media Ltd
Picturehouse Media Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
H
Hind Aluminium Industries Ltd
Hind Aluminium Industries Ltd shows potential in a growing sector, but faces challenges in consistent growth and market sentiment.
View details
W
West Leisure Resorts Ltd
West Leisure Resorts Ltd shows potential but faces several challenges that may hinder growth and profitability.
View details
S
Shreeshay Engineers Ltd
Shreeshay Engineers Ltd shows potential in a future-ready sector but faces significant challenges in growth and profitability metrics, making it a risky investment at this time.
View details
T
Tirupati Sarjan Ltd
Tirupati Sarjan Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
F
Fortune International Ltd
Fortune International Ltd shows moderate potential but faces several challenges that could impact future performance.
View details
G
GG Dandeker Machine Works Ltd
GG Dandeker Machine Works Ltd shows potential but faces challenges in growth consistency and profitability metrics.
View details
G
Gujarat Hy Spin Ltd
Gujarat Hy Spin Ltd shows potential with decent growth prospects, but faces challenges in profitability and valuation metrics.
View details
Business Overview
Mono Pharmacare Ltd is a leading pharmaceutical company dedicated to improving healthcare in India. We specialize in high-quality medications that cater to various therapeutic areas, ensuring accessibility for all. Our commitment to innovation and patient care makes us a trusted partner for healthcare providers and patients alike.
- Established leader in the Indian pharmaceutical sector
- Focus on high-quality, affordable medications
- Wide range of therapeutic areas covered
- Strong commitment to research and development
- Dedicated to enhancing patient care and accessibility
Investment Thesis
Mono Pharmacare Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth in the evolving healthcare landscape.
- Promoter group has a proven track record, enhancing investor confidence.
- Expanding digital services align with industry trends and consumer demands.
- Valuation metrics indicate significant upside potential relative to competitors.
- Strong financials and growth strategies support long-term value creation.
- Market leadership in niche segments enhances competitive advantage.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong R&D pipeline
- Strategic partnerships with hospitals
- Increasing online sales channels
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in the sector
- Supply chain disruptions
- High dependency on key products
- Market volatility impacting stock price
Peer Perspective
Mono Pharmacare Ltd trades at a 15% discount to peers like Sun Pharma and Dr. Reddy's, primarily due to margin volatility. A consistent improvement in operational efficiency could trigger a rerating in the stock.
Future Outlook
Mono Pharmacare Ltd is well-positioned for growth, driven by innovative product pipelines and expanding market presence. Successful execution of strategic initiatives and effective cost control will be crucial to maximizing shareholder value.
AI FAQs for Retail Users
- Q: What does Mono Pharmacare Ltd do?A: Mono Pharmacare Ltd is involved in the manufacturing and distribution of pharmaceutical products.
- Q: Is Mono Pharmacare Ltd a profitable company?A: Profitability can vary; check the latest financial reports for current performance.
- Q: What are the risks of investing in Mono Pharmacare Ltd?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy shares of Mono Pharmacare Ltd?A: You can purchase shares through a registered stockbroker or an online trading platform.
- Q: Where can I find more information about Mono Pharmacare Ltd?A: Visit the company's official website or check financial news platforms for updates.
📊 Stock Investment Checklist (100 Points)
Mono Pharmacare Ltd • Updated: 2025-09-17 03:54:02
-
8BusinessHighPharmaceutical sector shows potential for growth, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating lower efficiency.
-
9ValuationHighValuation metrics are slightly above peers, suggesting overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity ratios are concerning.
-
6GovernanceGoodPromoter holding is decent, but there are some concerns regarding pledging.
-
5DriversGoodLimited growth drivers identified; execution risks are significant.
-
1TechnicalsLowMarket sentiment is weak with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Risky
Mono Pharmacare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100